Discover July 2025's high-yield stock picks targeting a 12% CAGR. Outperform benchmarks with superior dividends and five-year ...

Merck & Co., Inc.'s 4.09% dividend yield and robust pipeline signal strong growth potential. Click here to read an analysis ...

AppLovin reported excellent results in the previous quarter with significant YoY improvement in margins and revenue. Learn ...

Pfizer ends phase 2 trial of maplirpacept for large B-cell lymphoma due to recruitment issues, not safety concerns. Read more here.

Energy's high costs and thin margins keep its financials under pressure. Click to read more on why URG remains a Hold.

Seeking Alpha's daily roundup of remarks and statements that could impact the technology sector. Read more here.